share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Hoge Stephen

SEC announcement ·  Mar 6 06:54
Summary by Futu AI
Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of 309 shares of common stock on 03/04/2024. The transaction was executed at a price of $94.3383 per share, resulting in a total market value of $29,150.53. This sale followed an acquisition of 652 shares through the exercise of derivative securities on 03/01/2024. After these transactions, Hoge's direct holdings in Moderna amount to 1,516,241 shares. Additionally, Hoge has indirect beneficial ownership of 156,049 shares through entities such as Valhalla, LLC and a Trust.
Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of 309 shares of common stock on 03/04/2024. The transaction was executed at a price of $94.3383 per share, resulting in a total market value of $29,150.53. This sale followed an acquisition of 652 shares through the exercise of derivative securities on 03/01/2024. After these transactions, Hoge's direct holdings in Moderna amount to 1,516,241 shares. Additionally, Hoge has indirect beneficial ownership of 156,049 shares through entities such as Valhalla, LLC and a Trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.